| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(97)80421-7 |
| P698 | PubMed publication ID | 9075663 |
| P50 | author | Wolfgang Stremmel | Q50772068 |
| P2093 | author name string | G Rudolph | |
| A Stiehl | |||
| S Walker | |||
| C Benz | |||
| P Sauer | |||
| L Theilmann | |||
| P2860 | cites work | Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis | Q24542418 |
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology | Q34494124 | ||
| Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis | Q37755869 | ||
| Advances in primary sclerosing cholangitis | Q37940713 | ||
| Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients | Q39770620 | ||
| Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis. | Q40571654 | ||
| Therapeutic investigations in primary sclerosing cholangitis | Q44666594 | ||
| Primary sclerosing cholangitis: surgical options, prognostic variables and outcome | Q50155200 | ||
| Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome | Q50188783 | ||
| Primary sclerosing cholangitis: refinement and validation of survival models | Q52409393 | ||
| Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. | Q54072767 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| Natural history and prognostic variables in primary sclerosing cholangitis | Q67915561 | ||
| Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial | Q68019501 | ||
| Ursodeoxycholic acid for primary sclerosing cholangitis | Q68095108 | ||
| Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis | Q68127327 | ||
| Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid | Q68842156 | ||
| Endoscopic treatment of biliary duct strictures in sclerosing cholangitis: follow-up assessment of a new therapeutic approach | Q68959407 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis | Q71004336 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period | Q72503309 | ||
| Primary sclerosing cholangitis | Q72596376 | ||
| P433 | issue | 3 | |
| P921 | main subject | primary sclerosing cholangitis | Q1058608 |
| P304 | page(s) | 560-566 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study | |
| P478 | volume | 26 |
| Q77882733 | Adaptive hepatic changes in mild stenosis of the common bile duct in the rat |
| Q34672135 | Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis |
| Q37926905 | Benign biliary strictures: current endoscopic management |
| Q50723714 | Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels. |
| Q24234678 | Bile acids for primary sclerosing cholangitis |
| Q24248730 | Bile acids for primary sclerosing cholangitis |
| Q33870255 | Chronic cholestatic diseases |
| Q37182946 | Clinical features and management of primary sclerosing cholangitis |
| Q35068031 | Current management of primary biliary cirrhosis and primary sclerosing cholangitis |
| Q34028003 | Current therapies and clinical controversies in the management of primary sclerosing cholangitis |
| Q43878341 | Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment |
| Q90354788 | Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practices |
| Q34687676 | Drug therapy of primary biliary diseases: classical and modern strategies. |
| Q51226271 | Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. |
| Q45045457 | Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis |
| Q67224415 | Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis |
| Q37355773 | Endoscopic and surgical management of primary sclerosing cholangitis. |
| Q26795782 | Endoscopic management of benign biliary strictures |
| Q38329038 | Endoscopic management of benign biliary strictures. |
| Q73389033 | Endoscopic therapy for inflammatory bowel disease |
| Q36119492 | Endoscopic treatment of dominant stenoses in patients with primary sclerosing cholangitis |
| Q37206473 | Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis |
| Q37477438 | Facing the Challenge of Acute Autoimmune Liver Disease: Report of a Case and Review of the Literature |
| Q24241009 | Glucocorticosteroids for primary sclerosing cholangitis |
| Q24246617 | Glucocorticosteroids for primary sclerosing cholangitis |
| Q24250522 | Glucocorticosteroids for primary sclerosing cholangitis |
| Q33966083 | Hepatobiliary complications of inflammatory bowel disease |
| Q52067430 | Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. |
| Q51165355 | In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment. |
| Q77373443 | Influence of cholestasis on absorption of ursodeoxycholic acid |
| Q50194548 | Influence of technical advancements on the management of biliary tract diseases |
| Q43433946 | Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis |
| Q55111560 | Management Of Primary Sclerosing Cholangitis. |
| Q33591454 | Mechanism of hepatoprotective action of bile salts in liver disease |
| Q35734498 | Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease |
| Q34017604 | Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets |
| Q81724957 | Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis |
| Q44503500 | Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid |
| Q43876511 | Multidisciplinary approach to benign biliary strictures |
| Q35027711 | Pancreatic and biliary tract disorders in inflammatory bowel disease |
| Q77129334 | Primary Sclerosing Cholangitis |
| Q44736208 | Primary sclerosing cholangitis |
| Q79866264 | Primary sclerosing cholangitis |
| Q81781641 | Primary sclerosing cholangitis |
| Q33672624 | Primary sclerosing cholangitis. |
| Q26829216 | Primary sclerosing cholangitis: diagnosis and treatment |
| Q47112995 | Primary sclerosing cholangitis: diagnostic and management challenges |
| Q77697172 | Primary sclerosing cholangitis: neoplastic potential in bile ducts, colon and the pancreas? |
| Q37618721 | Primary sclerosing cholangitis: the role of extrahepatic biliary resection |
| Q35595601 | Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. |
| Q54982596 | Searching for Bacterial Biofilm in Recurrent Cholangitis in Primary Sclerosing Cholangitis: A Case Presentation and Introduction of an Unexplored Disease Mechanism. |
| Q35046523 | The management of primary sclerosing cholangitis |
| Q81048479 | The management of primary sclerosing cholangitis |
| Q81194314 | The medical management of primary sclerosing cholangitis |
| Q34182672 | Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis |
| Q34027595 | Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid |
| Q80055608 | Treatment of primary sclerosing cholangitis |
| Q77598543 | Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications |
| Q28377666 | Ursodeoxycholic acid therapy in hepatobiliary disease |
| Q33866782 | Ursodeoxycholic acid treatment of vanishing bile duct syndromes |
| Q73015242 | [Primary sclerosing cholangitis (psc): diagnosis and therapy] |
| Q81009589 | [Primary sclerosing cholangitis] |
| Q79320444 | [Treatment of cholestatic hepatic diseases: more than the substitution of fat soluble vitamins?] |
Search more.